{"id":17995,"date":"2026-10-15T14:58:46","date_gmt":"2026-10-15T12:58:46","guid":{"rendered":"https:\/\/www.interpharma.ch\/?p=17995"},"modified":"2026-10-26T12:28:02","modified_gmt":"2026-10-26T11:28:02","slug":"three-questions-to-markus-isenmann-country-lead-sanofi-switzerland","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\/","title":{"rendered":"Three questions to Markus Isenmann, Country Lead Sanofi Switzerland"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"900\" src=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-1200x900.jpg\" alt=\"Portrait of Markus Isenmann, Country Lead of Sanofi Switzerland\" class=\"wp-image-17996\" srcset=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-1200x900.jpg 1200w, https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-800x600.jpg 800w, https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-768x576.jpg 768w, https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-1536x1152.jpg 1536w, https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-2048x1536.jpg 2048w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/><\/figure>\n\n\n\n<h2 id=\"h-you-lead-sanofi-switzerland-as-country-lead-what-drives-you-personally-in-this-role-and-what-is-your-vision-for-sanofi-s-contribution-to-healthcare-in-switzerland\" class=\"wp-block-heading\"><strong>You lead Sanofi Switzerland as Country Lead. What drives you personally in this role, and what is your vision for Sanofi&#8217;s contribution to healthcare in Switzerland?<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">I am driven by the conviction that medical progress only fulfills its true purpose when it reaches the people who need it. At Sanofi, we are committed to immunology, rare diseases, and vaccines. My vision is a Switzerland where patients have rapid access to new treatment options \u2013 and where we, as Sanofi, actively contribute to this.<\/p>\n\n\n\n<h2 id=\"h-the-swiss-pharmaceutical-industry-is-under-increasing-pressure-from-international-price-referencing-systems-in-your-view-what-impact-does-this-have-on-patient-access-and-what-is-needed-to-strengthen-switzerland-as-a-leading-life-sciences-hub\" class=\"wp-block-heading\"><strong>The Swiss pharmaceutical industry is under increasing pressure from international price referencing systems. In your view, what impact does this have on patient access, and what is needed to strengthen Switzerland as a leading life sciences hub?<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Switzerland has one of the most innovative healthcare systems in the world \u2013 yet patients here are increasingly struggling to access new therapies in a timely manner. Constructive dialogue between all stakeholders is essential to find solutions that ensure both access to medical innovations and the long-term financial sustainability of the system. In my opinion, new therapies are not cost drivers \u2013 they are an investment in the health of the population and in the future of the healthcare system.<\/p>\n\n\n\n<h2 id=\"h-as-a-member-of-interpharma-s-market-committee-what-are-your-priorities-and-where-do-you-see-the-greatest-opportunities\" class=\"wp-block-heading\"><strong>As a member of<\/strong> <strong>Interpharma&#8217;s Market Committee: What are your priorities, and where do you see the greatest opportunities?<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">For me, open dialogue is paramount \u2013 driven by a shared commitment to develop pragmatic solutions that benefit the entire healthcare system. The greatest opportunity I see lies in further developing Switzerland as a location where medical progress and sustainable financial viability are not opposites but mutually reinforce each other.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>You lead Sanofi Switzerland as Country Lead. What drives you personally in this role, and what is your vision for Sanofi&#8217;s contribution to healthcare in Switzerland? I am driven by the conviction that medical progress only fulfills its true purpose when it reaches the people who need it. At Sanofi, we are committed to immunology, [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":17996,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[128,181],"class_list":["post-17995","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-pharmaceutical-location","tag-patientenzugang"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.8 (Yoast SEO v28.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Three questions to Markus Isenmann, Sanofi Switzerland<\/title>\n<meta name=\"description\" content=\"Markus Isenmann, Country Lead Sanofi Switzerland, on medical progress that reaches patients and timely access to new therapies in Switzerland.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Three questions to Markus Isenmann, Country Lead Sanofi Switzerland\" \/>\n<meta property=\"og:description\" content=\"Markus Isenmann, Country Lead Sanofi Switzerland, on medical progress that reaches patients and timely access to new therapies in Switzerland.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-15T12:58:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-26T11:28:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1920\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"lukaskuemmerli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"lukaskuemmerli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\\\/\"},\"author\":{\"name\":\"lukaskuemmerli\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/person\\\/2854d813965ba4a7feaeffbe96f8eadf\"},\"headline\":\"Three questions to Markus Isenmann, Country Lead Sanofi Switzerland\",\"datePublished\":\"2026-10-15T12:58:46+00:00\",\"dateModified\":\"2026-10-26T11:28:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\\\/\"},\"wordCount\":276,\"publisher\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Bild_Markus_Isenmann_4zu3-scaled.jpg\",\"keywords\":[\"Pharmaceutical location\",\"Patientenzugang\"],\"inLanguage\":\"en-US\",\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\\\/\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\\\/\",\"name\":\"Three questions to Markus Isenmann, Sanofi Switzerland\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Bild_Markus_Isenmann_4zu3-scaled.jpg\",\"datePublished\":\"2026-10-15T12:58:46+00:00\",\"dateModified\":\"2026-10-26T11:28:02+00:00\",\"description\":\"Markus Isenmann, Country Lead Sanofi Switzerland, on medical progress that reaches patients and timely access to new therapies in Switzerland.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Bild_Markus_Isenmann_4zu3-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Bild_Markus_Isenmann_4zu3-scaled.jpg\",\"width\":2560,\"height\":1920,\"caption\":\"Portrait of Markus Isenmann, Country Lead of Sanofi Switzerland\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Three questions to Markus Isenmann, Country Lead Sanofi Switzerland\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#website\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.interpharma.ch\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/interpharma_ch\",\"https:\\\/\\\/ch.linkedin.com\\\/company\\\/interpharma\",\"https:\\\/\\\/www.instagram.com\\\/interpharma_ch\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/person\\\/2854d813965ba4a7feaeffbe96f8eadf\",\"name\":\"lukaskuemmerli\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g\",\"caption\":\"lukaskuemmerli\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Three questions to Markus Isenmann, Sanofi Switzerland","description":"Markus Isenmann, Country Lead Sanofi Switzerland, on medical progress that reaches patients and timely access to new therapies in Switzerland.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\/","og_locale":"en_US","og_type":"article","og_title":"Three questions to Markus Isenmann, Country Lead Sanofi Switzerland","og_description":"Markus Isenmann, Country Lead Sanofi Switzerland, on medical progress that reaches patients and timely access to new therapies in Switzerland.","og_url":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\/","og_site_name":"Interpharma","article_published_time":"2026-10-15T12:58:46+00:00","article_modified_time":"2026-10-26T11:28:02+00:00","og_image":[{"width":2560,"height":1920,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-scaled.jpg","type":"image\/jpeg"}],"author":"lukaskuemmerli","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"Written by":"lukaskuemmerli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\/"},"author":{"name":"lukaskuemmerli","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/2854d813965ba4a7feaeffbe96f8eadf"},"headline":"Three questions to Markus Isenmann, Country Lead Sanofi Switzerland","datePublished":"2026-10-15T12:58:46+00:00","dateModified":"2026-10-26T11:28:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\/"},"wordCount":276,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-scaled.jpg","keywords":["Pharmaceutical location","Patientenzugang"],"inLanguage":"en-US","copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\/","url":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\/","name":"Three questions to Markus Isenmann, Sanofi Switzerland","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-scaled.jpg","datePublished":"2026-10-15T12:58:46+00:00","dateModified":"2026-10-26T11:28:02+00:00","description":"Markus Isenmann, Country Lead Sanofi Switzerland, on medical progress that reaches patients and timely access to new therapies in Switzerland.","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-scaled.jpg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-scaled.jpg","width":2560,"height":1920,"caption":"Portrait of Markus Isenmann, Country Lead of Sanofi Switzerland"},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/en\/blog\/three-questions-to-markus-isenmann-country-lead-sanofi-switzerland\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/en\/"},{"@type":"ListItem","position":2,"name":"Three questions to Markus Isenmann, Country Lead Sanofi Switzerland"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/2854d813965ba4a7feaeffbe96f8eadf","name":"lukaskuemmerli","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g","caption":"lukaskuemmerli"}}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts\/17995","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/comments?post=17995"}],"version-history":[{"count":2,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts\/17995\/revisions"}],"predecessor-version":[{"id":18285,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts\/17995\/revisions\/18285"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/media\/17996"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/media?parent=17995"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/tags?post=17995"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}